Category: Advocacy

Initiative 5%: Call for proposal on operational research “ Improvement in tuberculosis screening, treatment and prevention”

Source: Initiative 5% website The 5% Initiative is the second mechanism for France’s contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF). The operational implementation of this Initiative has been entrusted to Expertise France ( the French...

/ 1 October 2018

The MENA Community Advisory Board (MENA-CAB) 2017 Report

The Community Advisory Board (CAB) constitutes a space of exchange between advocates from the MENA region,  researchers and drug manufacturers, with the aim to educate people living with HIV and their advocates on access to treatment, to disseminate information about...

/ 14 September 2018

HRC38: Human Rights Council set to adopt resolution on Human rights in the context of HIV and AIDS

On Thursday, 28 June 2018, the delegations of Brazil, Colombia, Mozambique, Portugal, and Thailand submitted a draft resolution on “Human rights in the context of HIV and AIDS” to the 38th session of the Human Rights Council. The text of...

/ 29 June 2018

Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!

Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance to first line ARVs? GNP+ invites you to...

/ 16 February 2018

Global Fund MENA Regional Platform is relaunched

ITPC-MENA continues as the host for the Middle East and North Africa region As a key component of the Global Fund’s Community, Rights and Gender Strategic Initiative, the Regional Platform for Communication and Coordination will continue to support and facilitate...

/ 8 February 2018

New Study : Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)

Title: A tool to assess how friendly to access-to-medicines your law is Background Provisions of intellectual property (IP) may have an important impact on access to medicines. For instance, the monopoly granted by the patent prevents competition with generics on...

/ 26 October 2017

Job offer for the MENA regional platform manager on Global Fund and Civil Society

JOB DESCRIPTION: REGIONAL GLOBAL FUND PLATFORM MANAGER ABOUT ITPC-MENA: International Treatment Preparedness Coalition (ITPC) Middle East & North Africa (MENA) is a regional non governmental organization operating in the Middle East and North Africa region regrouping a network of community...

/ 19 September 2017

IAS 2017: Closing ceremony exposes Gilead Sciences

Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community address delivered by Othoman Mellouk, during the closing...

/ 26 July 2017

A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt

The 9th International AIDS Society Conference on HIV / AIDS 2017 : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt, a victory for ITPC-MENA Today, at the World Conference on AIDS, which is currently taking place in Paris...

/ 25 July 2017

BLOG: We want dolutegravir for all, and we want it now

Source: makemedicinesaffordable Author: Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC). Article first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to be...

/ 25 July 2017